Mechanistic Insights into Copper-Catalyzed Azide–Alkyne Cycloaddition (CuAAC): Observation of Asymmetric Amplification

Takao Osako; Yasuhiro Uozumi

doi:10.1055/s-0034-1380534

Synlett, Table of Contents

Synlett 2015; 26(11): 1475-1479
DOI: 10.1055/s-0034-1380534

letter

Mechanistic Insights into Copper-Catalyzed Azide–Alkyne Cycloaddition (CuAAC): Observation of Asymmetric Amplification

Takao Osako

^aInstitute for Molecular Science (IMS), Okazaki, Aichi 444-8787, Japan Email: uo@ims.ac.jp

,

Yasuhiro Uozumi*

^aInstitute for Molecular Science (IMS), Okazaki, Aichi 444-8787, Japan Email: uo@ims.ac.jp

^bRIKEN Center for Sustainable Resource Science, Wako, Saitama 351-0198, Japan Email: uo@riken.jp

› Author Affiliations

Abstract

All articles of this category

Dedicated to Professor Peter Vollhardt for his peerless contribution to the broad discipline of organic chemistry

Abstract

A mechanistic study of copper-catalyzed azide–alkyne cycloaddition (CuAAC) was examined using an enantioposition-selective asymmetric CuAAC as a probe reaction system. Based on the observed asymmetric amplification (a positive nonlinear effect), we proposed that a dimeric chiral copper complex is involved as a reactive intermediate in the copper-catalyzed azide–alkyne cycloaddition.

Key words

asymmetric catalysis - azide–alkyne cycloaddition - Huisgen reaction - nonlinear effect

Full Text

References

References and Notes
1 Kolb HC, Finn MG, Sharpless KB. Angew. Chem. Int. Ed. 2001; 40: 2004

2a Organic Azides: Syntheses and Applications . Bräse S, Banert K. John Wiley and Sons; Chichester: 2010

For recent selected reviews on CuAAC, see:

2b Bock VD, Hiemstra H, van Maarseveen JH. Eur. J. Org. Chem. 2006; 51
2c Mose JE, Moorhouse AD. Chem. Soc. Rev. 2007; 36: 1249
2d Wu P, Fokin VV. Aldrichimica Acta 2007; 40: 7
2e Meldal M, Tornøe CW. Chem. Rev. 2008; 108: 2952
2f Hein JE, Fokin VV. Chem. Soc. Rev. 2010; 39: 1302
2g Agalave SG, Maujan SR, Pore VS. Chem. Asian J. 2011; 6: 2696
2h Lallana E, Riguera R, Fernandez-Megia E. Angew. Chem. Int. Ed. 2011; 50: 8794

3a Meng J.-c, Fokin VV, Finn MG. Tetrahedron Lett. 2005; 46: 4543
3b Zhou F, Tan C, Tang J, Zhang Y.-Y, Gao W.-M, Wu H.-H, Yu Y.-H, Zhou J. J. Am. Chem. Soc. 2013; 135: 10994

4a Hayashi T, Niizuma S, Kamikawa T, Suzuki N, Uozumi Y. J. Am. Chem. Soc. 1995; 117: 9101
4b Kamikawa T, Uozumi Y, Hayashi T. Tetrahedron Lett. 1996; 37: 3161
4c Zhou H, Uozumi Y. Synlett 2013; 24: 2550

5a Osako T, Panichakul D, Uozumi Y. Org. Lett. 2012; 14: 194
5b Yamada YM. A, Sarkar S, Uozumi Y. J. Am. Chem. Soc. 2012; 134: 9285

6 Osako T, Uozumi Y. Org. Lett. 2014; 16: 5866

See reviews in ref. 2. For typical recent reports, see also:

7a Himo F, Lovell T, Hilgraf R, Rostovtsev VV, Noodleman L, Sharpless KB, Fokin VV. J. Am. Chem. Soc. 2005; 127: 210
7b Rodionov VO, Fokin VV, Finn MG. Angew. Chem. Int. Ed. 2005; 44: 2210
7c Rodionov LO, Presolski SI, Díaz DD, Fokin VV, Finn MG. J. Am. Chem. Soc. 2007; 129: 12705
7d Ahlquist M, Fokin VV. Organometallics 2007; 26: 4389
7e Straub BF. Chem. Commun. 2007; 3868
7f Hein JE, Tripp JC, Krasnova LB, Sharpless KB, Fokin VV. Angew. Chem. Int. Ed. 2009; 48: 8018
7g Partyka DV, Gao L, Teets TS, Updegraff JB. III, Deligounul N, Gray TG. Organometallics 2009; 28: 6171
7h Zhou Y, Lecourt T, Micouin L. Angew. Chem. Int. Ed. 2010; 49: 2607
7i Presolski SI, Hong V, Cho S.-H, Finn MG. J. Am. Chem. Soc. 2010; 132: 14570
7j Kuang G.-C, Guha PM, Brotherton WS, Simmons JT, Stankee LA, Nguyen BT, Clark RJ, Zhu L. J. Am. Chem. Soc. 2011; 133: 13984
7k Worrell BT, Malik JA, Fokin VV. Science 2013; 340: 457

8a Kagan HB, Fiaud JC. Topics in Stereochemistry . Vol. 18. Eliel EL, Fiaud JC. Wiley; New York: 1988: 249-330
8b Kagan HB. Synlett 2001; 888
8c Guillaneux D, Zhao S.-H, Samuel O, Rainford D, Kagan HB. J. Am. Chem. Soc. 1994; 116: 9430
8d Johnson DW. Jr, Singleton DA. J. Am. Chem. Soc. 1999; 121: 9307

9 The curve fittings were generated from ee_product = 2ee₀ee_ligand/(1 + ee_ligand ²) for the enantioposition-selective CuAAC or from DKEE = 2DKEE₀ee_ligand/(1 + ee_ligand ²) for the kinetic resolution by the asymmetric CuAAC [K = 4, g = 0; statistical distribution conditions were applied for the formation of the potential reactive intermediates {chiral dimeric complexes (ML^R)₂, (ML^s)₂, and meso dimeric complex [(ML^R)(ML^s)]}.
10 The reaction of 1a with 2 was examined with homochiral [Cu^I(L*)(triazole)]₂(OTf)₂ (metal/ligand = 1:1), which was prepared, isolated, and fully characterized (unpublished) to give (R)-3a in 65% yield and 82% ee, along with a 24% yield of bistriazole 4a, being in good agreement with the results shown in Table 1. This observation demonstrated that the catalytically active species should be a 1:1 Cu–L* complex. Thus, we excluded the possibility that a positive NLE is induced via the formation of an inactive 1:2 metal–ligand heterochiral complex, cf.: Saaby S, Nakama K, Lie MA, Hazell RG, Jørgensen KA. Chem. Eur. J. 2003; 9: 6145
11 Procedure for the Copper-Catalyzed Cycloaddition In a glove box, CuOTf·(C₆H₆)_0.5 (3.1 mg, 0.0125 mmol Cu) was charged into a screw vial. A solution of L* (12.6 mg, 0.025 mmol) in 1,2-DCE (250 μL) was added, and the mixture was stirred for 30 min. After addition of a solution of dialkyne 1a (0.125 mmol) in 1,2-DCE (250 μL) to the mixture, the reaction vial was taken from the glove box. After addition of benzyl azide (2, 24 μL, 0.188 mmol), the mixture was stirred at r.t. for 3 h. The resulting mixture was purified by flash SiO₂ column to give the products 3a and 4a. Compound 3a: ¹H NMR (396 MHz, CDCl₃, 25 °C): δ = 8.39 (d, J = 7.5 Hz, 1 H, Ar), 7.80 (t, J = 7.5 Hz, 2 H, Ar), 7.67 (d, J = 7.5 Hz, 1 H, Ar), 7.52 (t, J = 7.9 Hz, Ar), 7.41 (t, J = 7.9 Hz, 2 H, Ar), 7.33–7.25 (m, 4 H, Ar), 7.19 (t, J = 7.5 Hz, 2 H, Ar), 6.68 (d, J = 7.1 Hz, 2 H, Ar), 5.61 (s, 1 H, triazole-H5), 5.08 (s, 2 H, PhCH₂), 2.69 (s, 1 H, CH). ¹³C{¹H} NMR (100 MHz, CDCl₃, 25 °C): δ = 145.52, 140.31, 137.33, 133.97, 133.26, 132.60, 131.54, 131.14, 128.86, 128.47, 128.30, 128.23, 128.15, 128.12, 127.54, 127.31, 126.50, 126.00, 125.39, 125.24, 123.41, 121.88, 82.30, 80.49, 53.58. HRMS: m/z calcd for C₂₇H₁₉N₃: 385.1579; found: 385.1576. IR (ATR, neat): 3286, 3261, 3057, 2959, 2936, 1945, 1878, 1721, 1606, 1593, 1574, 1547, 1496, 1453, 1438, 1391, 1370, 1348, 1296, 1261, 1247, 1229, 1214, 1156, 1121, 1094, 1074, 1050, 1026, 1007, 976, 962, 912, 893, 871, 846, 827, 798, 778, 756, 727, 691, 676, 661, 640, 628, 610, 589, 577, 566 cm^–1. 91% ee from 1.5 equiv of 2 (HPLC conditions: Chiralpak IA column, MTBE, flow rate 1 mL min^–1, wavelength = 255 nm, t _R = 9.5 min for minor isomer, t _R = 11.6 min for major isomer). [α]_D ²⁶ –82.5 (c 0.83, CHCl₃). The absolute configuration of 3a was determined to be R based on the crystal structure of 3 bearing chloro group at the 4-position of the phenyl ring. For details, see ref. 6. Compound 4a: ¹H NMR (396 MHz, CDCl₃, 25 °C): δ = 8.32 (dd, J = 7.5, 1.2 Hz, 2 H, Ar), 7.73 (d, J = 8.3 Hz, 1 H, Ar), 7.68 (t, J = 7.9 Hz, 2 H, Ar), 7.39 (t, J = 7.9 Hz, 1 H, Ar), 7.33–7.13 (m, 4 H, Ar), 6.68 (d, J = 7.9 Hz, 4 H, Ar), 5.66 (s, 2 H, triazole-H5), 5.10 (s, 4 H, PhCH₂). ¹³C{¹H} NMR (100 MHz, CDCl₃, 25 °C): δ = 146.10, 137.74, 135.07, 134.11, 133.11, 131.66, 131.14, 128.81, 128.75, 128.28, 128.24, 128.18, 127.65, 127.52, 126.92, 126.29, 125.48, 125.09, 121.72, 53.54. HRMS: m/z calcd for C₃₄H₂₆N₆Na₁: 541.2117; found: 541.2116. IR (ATR, neat): 3157, 3051, 2929, 2853, 2389, 2279, 1957, 1724, 1661, 1629, 1590, 1549, 1497, 1433, 1389, 1342, 1292, 1248, 1223, 1158, 1106, 1072, 1048, 921, 800, 779, 751, 704, 612, 588 cm^–1.